Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Small round cell sarcomas.

Lessnick SL, Dei Tos AP, Sorensen PH, Dileo P, Baker LH, Ferrari S, Hall KS.

Semin Oncol. 2009 Aug;36(4):338-46. doi: 10.1053/j.seminoncol.2009.06.006. Review.

PMID:
19664494
2.

Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group Study.

Granowetter L, Womer R, Devidas M, Krailo M, Wang C, Bernstein M, Marina N, Leavey P, Gebhardt M, Healey J, Shamberger RC, Goorin A, Miser J, Meyer J, Arndt CA, Sailer S, Marcus K, Perlman E, Dickman P, Grier HE.

J Clin Oncol. 2009 May 20;27(15):2536-41. doi: 10.1200/JCO.2008.19.1478. Epub 2009 Apr 6.

3.

Analysis of prognostic factors in ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital studies.

Rodríguez-Galindo C, Liu T, Krasin MJ, Wu J, Billups CA, Daw NC, Spunt SL, Rao BN, Santana VM, Navid F.

Cancer. 2007 Jul 15;110(2):375-84.

4.

Treatment of Ewing sarcoma family of tumors: current status and outlook for the future.

Rodriguez-Galindo C, Spunt SL, Pappo AS.

Med Pediatr Oncol. 2003 May;40(5):276-87. Review. Erratum in: Med Pediatr Oncol. 2003 Dec;41(6):594.

PMID:
12652615
5.

Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.

Grier HE, Krailo MD, Tarbell NJ, Link MP, Fryer CJ, Pritchard DJ, Gebhardt MC, Dickman PS, Perlman EJ, Meyers PA, Donaldson SS, Moore S, Rausen AR, Vietti TJ, Miser JS.

N Engl J Med. 2003 Feb 20;348(8):694-701.

6.

Localised Ewing sarcoma/PNET of bone--prognostic factors and international data comparison.

Jenkin RD, Al-Fawaz I, Al-Shabanah M, Allam A, Ayas M, Khafaga Y, Memon M, Rifai S, Schultz H, Younge D.

Med Pediatr Oncol. 2002 Dec;39(6):586-93.

PMID:
12376982
7.

Prognostic impact of chromosomal aberrations in Ewing tumours.

Hattinger CM, Pötschger U, Tarkkanen M, Squire J, Zielenska M, Kiuru-Kuhlefelt S, Kager L, Thorner P, Knuutila S, Niggli FK, Ambros PF, Gadner H, Betts DR.

Br J Cancer. 2002 Jun 5;86(11):1763-9.

8.

Alternative EWS-FLI1 fusion gene and MIC2 expression in peripheral and central primitive neuroectodermal tumors.

Ishii N, Hiraga H, Sawamura Y, Shinohe Y, Nagashima K.

Neuropathology. 2001 Mar;21(1):40-4.

PMID:
11304041
9.

Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86.

Paulussen M, Ahrens S, Dunst J, Winkelmann W, Exner GU, Kotz R, Amann G, Dockhorn-Dworniczak B, Harms D, Müller-Weihrich S, Welte K, Kornhuber B, Janka-Schaub G, Göbel U, Treuner J, Voûte PA, Zoubek A, Gadner H, Jürgens H.

J Clin Oncol. 2001 Mar 15;19(6):1818-29.

PMID:
11251014
10.

In situ reverse-transcriptase polymerase chain reaction demonstration of the EWS/FLI-1 fusion transcript in Ewing's sarcomas and peripheral primitive neuroectodermal tumors.

Krams M, Peters J, Boeckel F, Raether A, Ambros PF, Parwaresch R, Harms D.

Virchows Arch. 2000 Sep;437(3):234-40.

PMID:
11037342
11.

Prognostic impact of INK4A deletion in Ewing sarcoma.

Wei G, Antonescu CR, de Alava E, Leung D, Huvos AG, Meyers PA, Healey JH, Ladanyi M.

Cancer. 2000 Aug 15;89(4):793-9.

PMID:
10951342
12.

Prognostic impact of P53 status in Ewing sarcoma.

de Alava E, Antonescu CR, Panizo A, Leung D, Meyers PA, Huvos AG, Pardo-Mindán FJ, Healey JH, Ladanyi M.

Cancer. 2000 Aug 15;89(4):783-92.

PMID:
10951341
13.

Association of EWS-FLI1 type 1 fusion with lower proliferative rate in Ewing's sarcoma.

de Alava E, Panizo A, Antonescu CR, Huvos AG, Pardo-Mindán FJ, Barr FG, Ladanyi M.

Am J Pathol. 2000 Mar;156(3):849-55.

14.

EWS-FLI1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing's sarcoma.

Ginsberg JP, de Alava E, Ladanyi M, Wexler LH, Kovar H, Paulussen M, Zoubek A, Dockhorn-Dworniczak B, Juergens H, Wunder JS, Andrulis IL, Malik R, Sorensen PH, Womer RB, Barr FG.

J Clin Oncol. 1999 Jun;17(6):1809-14.

PMID:
10561219
15.

Prognostic significance of serum LDH in Ewing's sarcoma of bone.

Bacci G, Ferrari S, Longhi A, Rimondini S, Versari M, Zanone A, Forni C.

Oncol Rep. 1999 Jul-Aug;6(4):807-11.

PMID:
10373661
16.

Overexpression of p53 protein in primary Ewing's sarcoma of bone: relationship to tumour stage, response and prognosis.

Abudu A, Mangham DC, Reynolds GM, Pynsent PB, Tillman RM, Carter SR, Grimer RJ.

Br J Cancer. 1999 Mar;79(7-8):1185-9.

17.

Evaluation of prognostic factors in a tumor volume-adapted treatment strategy for localized Ewing sarcoma of bone: the CESS 86 experience. Cooperative Ewing Sarcoma Study.

Ahrens S, Hoffmann C, Jabar S, Braun-Munzinger G, Paulussen M, Dunst J, Rübe C, Winkelmann W, Heinecke A, Göbel U, Winkler K, Harms D, Treuner J, Jürgens H.

Med Pediatr Oncol. 1999 Mar;32(3):186-95.

PMID:
10064186
18.

EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma.

de Alava E, Kawai A, Healey JH, Fligman I, Meyers PA, Huvos AG, Gerald WL, Jhanwar SC, Argani P, Antonescu CR, Pardo-Mindan FJ, Ginsberg J, Womer R, Lawlor ER, Wunder J, Andrulis I, Sorensen PH, Barr FG, Ladanyi M.

J Clin Oncol. 1998 Apr;16(4):1248-55. Erratum in: J Clin Oncol 1998 Aug;16(8):2895.

PMID:
9552022
19.

Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients?

Zoubek A, Dockhorn-Dworniczak B, Delattre O, Christiansen H, Niggli F, Gatterer-Menz I, Smith TL, Jürgens H, Gadner H, Kovar H.

J Clin Oncol. 1996 Apr;14(4):1245-51.

PMID:
8648380
20.

Combinatorial generation of variable fusion proteins in the Ewing family of tumours.

Zucman J, Melot T, Desmaze C, Ghysdael J, Plougastel B, Peter M, Zucker JM, Triche TJ, Sheer D, Turc-Carel C, et al.

EMBO J. 1993 Dec;12(12):4481-7.

Supplemental Content

Support Center